Conservative medical therapy of prosthetic joint infections: Retrospective analysis of an 8-year experience

Clinical Microbiology and Infection

Volumn 10, Issue 9, 2004, Pages 831-837

  Pavoni, G L ^a   Giannella, M ^a   Falcone, M ^a   Scorzolini, L ^a   Liberatore, M ^a   Carlesimo, B ^b   Serra, P ^a   Venditti, Mario ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Centro Paraplegici   (Italy)

Author keywords

Antibiotic therapy; Infected prosthetic joints; Prosthetic joint infections; Therapy

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFAMANDOLE; CEFUROXIME; CEFUROXIME AXETIL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; LEVOFLOXACIN; MINOCYCLINE; MOXIFLOXACIN; RIFAMPICIN; TECHNETIUM 99M; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; CONSERVATIVE TREATMENT; DRUG RESPONSE; ENTEROCOCCUS FAECALIS; FOLLOW UP; HUMAN; INFECTION CONTROL; JOINT SCINTISCANNING; LEUKOCYTE; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS INFECTION; PSEUDOMONAS AERUGINOSA; RELAPSE; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 4644240827     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2004.00928.x     Document Type: Article

References (22)

1. Steckelberg JM, Osmon DR. Prosthetic joint infections. In: Waldvogel FA, Bisno AL, eds. Infections associated with indwelling medical devices, 3rd edn. Washington DC: American Society for Microbiology, 2000; 173-209.
2. Stein A, Drancourt M, Raoult D. Ambulatory management of infected orthopedic implants. In: Waldvogel FA, Bisno AL, eds. Infections associated with indwelling medical devices, 3rd edn. Washington DC: American Society for Microbiology, 2000; 211-230.
3. Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis 1998; 27: 711-713.
4. Drancourt M, Stein A, Argenson JN, Roiron R, Groulier P, Raoult D. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother 1997; 39: 235-240.
5. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 1993; 37: 1214-1218.
6. Stein A, Bataille JF, Drancourt M et al. Ambulatory treatment of multidrug-resistant Staphylococcus-infected orthopedic implants with high-dose oral co-trimoxazole (trimethoprim-sulfamethoxazole). Antimicrob Agents Chemother 1998; 42: 3086-3091.
7. Zimmerli W, Ochsner PE. Management of infection associated with prosthetic joints. Infection 2003; 31: 99-108.
8. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections. A randomized controlled trial. JAMA 1998; 279: 1537-1541.
9. Vaudax P, Lew DP, Waldvogel FA. Host factors predisposing to and influencing therapy of foreign body infections. In: Bisno AL, Waldvogel FA, eds. Infections associated with indwelling medical devices, 2nd edn. Washington DC: American Society for Microbiology, 1994; 1-29.
10. Chuard C, Lucet JC, Rohner P et al. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis 1991; 163: 1369-1373.
11. Brandt CM, Sistrunk WW, Duffy MC et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997; 24: 914-919.
12. Tsukayama DT, Wicklund B, Gustilo RB. Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics 1991; 14: 841-844.
13. Schoifet SD, Morrey BF. Treatment of infection after total knee arthroplasty by debridement with retention of the components. J Bone Joint Surg Am 1990; 72: 1383-1390.
14. Tarasi A, Baiocchi P, Capone A, Tarasi D, Brandimarte C, Venditti M. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against S. aureus isolated from device associated infections unresponsive to glycopeptide therapy [abstract 863]. In: Program and abstracts of the 9th European Congress of Clinical Microbiology and Infectious Diseases. Berlin: European Society for Clinical Microbiology and Infectious Diseases, 1999; 385.
15. Pavoni GL, Falcone M, Baiocchi P et al. Conservative medical therapy of infections following osteosynthesis: a retrospective analysis of a six-year experience. J Chemother 2002; 14: 378-383.
16. Clumeck N, Marcelis L, Amiri-Lamraski MH, Gordts B. Treatment of severe staphylococcal infections with a rifampicin-minocycline association. J Antimicrob Chemother 1984; 13 (suppl C): 17-22.
17. Desplaces N, Acar JF. New quinolones in the treatment of joint and bone infections. Rev Infect Dis 1988; 10: 179-183.
18. Chuard C, Hermann M, Vaudax P, Waldvogel FA, Lew DP. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother 1991; 35: 2611-2616.
19. Tarasi A, Cassone M, Monaco M, Tarasi D, Pompeo ME, Venditti M. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy. J Chemother 2003; 15: 281-285.
20. Tattevin P, Crémieux AC, Pottier P, Huten D, Carbon C. Prosthetic joint infection: when can prosthesis salvage be considered? Clin Infect Dis 1999; 29: 292-295.
21. Tobin EH. Prosthetic joint infections: controversies and clues. Lancet 1999; 353: 770-771.
22. Brouqui P, Rousseau MC, Stein A, Drancourt M, Raoult D. Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination. Antimicrob Agents Chemother 1995; 39: 2423-2425.